- Abbott Labs agrees to amended merger agreement with Alere $ABT $ALR
- Aerpio Pharma files S-1 prospectus.
- Athersys proxy seeks to increase authorized share count $ATHX
- Aveo Pharma proxy seeks to increase authorized share count and reverse split $AVEO
- Baxter discloses subpoena related to criminal investigation $BAX
- Biolase private placement. $BIOL
- Cascadian Therapeutics proxy seeks to increase authorized share count $CASC
- Cellectar Biosciences proxy seeks to increase authorized share count $CLRB
- Eli Lilly and Incyte announce FDA complete response letter for JAK inhibitor baricitinib $LLY $INCY
- Endra Life Sciences files amended S-1 for IPO $NDRA
- INVO Bioscience won't file 10-K by extended deadline $IVOB
- Nabriva Therapeutics files for exchange offer $NBRV
- Nephros Inc files S-1 for selling shareholders $NEPH
- Neurotrope grants new options to execs $NTRP
- Opexa Therapeutics receives NASDAQ delisting notice $OPXA
- Pain Therapeutics files $75 million shelf $PTIE
- Sorrento Therapeutics sells 22m shares of stock $SRNE